Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05089771 crossover analgesia study in healthy volunteers
NL-OMON42223Active, not recruiting
- Sponsor
- Pfizer
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of PF-05089771 in chronic pain (5 arms), sponsored by Pfizer. Primary endpoints: Thermal pain (normal skin): pain detection threshold, Thermal pain (UVB skin): pain detection threshold and 3 more. Started Jan 2015; status: active, not recruiting.
02
Drugs
PF-05089771
03
Conditions
chronic pain
Beyond the preview
Go deeper on NL-OMON42223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42223.